Inhibition of miR-455-3p chemosensitizes ESCC cells and reduces the subpopulations of CD90+ and CD271+ T-ICs via the suppression of multiple T-IC-associated pathways, including the Wnt/β-catenin and TGF-β pathways. This evidence concerns the gene TGFB1 and esophageal squamous cell carcinoma.